Method and apparatus of determining atrial capture threshold while avoiding pacemaker mediated tachycardia

• US 6,618,622 B1
• Filed: 05/08/2001
• Issued: 09/09/2003
• Est. Priority Date: 05/14/1996
• Status: Expired due to Fees

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Levine, Paul A., Mann, Brian M., Endaya, Melinda
• Primary Examiner(s): Schaetzle, Kennedy
• Application Number:
  US09/851,715
• Time in Patent Office: 854 Days
• Field of Search: 607/28, 607/14, 607/9, 607/27
• US Class Current: 607/28
• CPC Class Codes: A61N 1/3712 Auto-capture, i.e. automatic adjustment of the stimulation threshold
• CPC Class Codes: A61N 1/3714 Atrial capture
• CPC Class Codes: A61N 1/37247 User interfaces, e.g. input or presentation means

Abstract

A pacemaker programmer and diagnostic system retrieves information stored within a pacemaker and analyzes the retrieved data in real time. The stored information can be retrieved by means of a telemetry communication link. The pacemaker automatically lengthens an AV delay. The pacemaker determines atrial capture by generating atrial stimulation pulses while maintaining the ventricular stimulation pulse amplitude at a level known to ensure ventricular capture, and by detecting loss of atrial capture. In response to the loss of atrial capture, a processor automatically records the atrial capture threshold, and restores the AV delay to its pre-test value. The pulse generator also delivers a backup atrial stimulation pulse concurrent with a ventricular stimulation pulse to reduce the possibility of a retrograde P-wave initiating a pacemaker-mediated tachycardia (PMT).

Claims

1. In a dual-chamber implantable stimulation device, a method of determining atrial capture threshold while avoiding pacemaker mediated tachycardias, the method comprising the steps of:

generating atrial and ventricular stimulation pulses while maintaining ventricular pulse amplitude at a level known to ensure capture in the ventricle;

automatically lengthening the AV Delay;

detecting capture based on the absence or presence of a P-wave with each atrial stimulation pulse corresponding to loss-of-capture or cardiac contraction, respectively;

adjusting atrial stimulation pulse amplitude until a loss of capture occurs; and

in response to a loss of capture, delivering a backup atrial stimulation pulse concurrent with the ventricular stimulation pulse.

2. The method, as recited in claim 1, further comprising the step of:

programmably lengthening the post-ventricular refractory period (PVARP) to further reduce the possibility of premature and retrograde P-waves being detected as true cardiac contractions.

3. A dual-chamber implantable stimulation device having means for determining atrial capture threshold while avoiding pacemaker mediated tachycardias, the device comprising:

a pulse generator configured to generate atrial and ventricular stimulation pulses to a patient'"'"'s heart;

detection circuitry, coupled to the pulse generator, configured to detect the absence or presence of P-waves with each atrial stimulation pulse corresponding to loss-of-capture or cardiac contraction, respectively; and

a processor, coupled to the pulse generator and the detection circuitry, programmed to automatically lengthen the AV Delay prior to triggering the pulse generator to initiate an atrial capture threshold test and, in response to a loss of capture, to restore the atrial stimulation pulse amplitude to a value above capture threshold, and further programmed to trigger the pulse generator to deliver a backup atrial stimulation pulse concurrent with the ventricular stimulation pulse.

4. The device, as recited in claim 3, wherein:

the device further comprises timing circuitry, coupled to the processor, configured to control a plurality of intervals including a post-ventricular refractory period (PVARP); and

the processor is further programmed to automatically lengthen the post-ventricular refractory period (PVARP) during the capture threshold test such that the possibility of premature and retrograde P-waves being detected as true cardiac contractions is reduced.

5. The device, as recited in claim 4, wherein:

the processor is further programmed to automatically restore the post ventricular refractory period (PVARP) subsequent to the capture threshold test.

6. A dual-chamber implantable stimulation device having means for determining atrial capture threshold while avoiding pacemaker mediated tachycardias, the device comprising:

pulse generating means for generating atrial and ventricular stimulation pulses to a patient'"'"'s heart;

detecting means for detecting the absence or presence of P-waves with each atrial stimulation pulse corresponding to loss-of-capture or cardiac contraction, respectively; and

control means, coupled to the pulse generating means and the detecting means, for automatically lengthening the AV Delay prior to triggering the pulse generating means to initiate an atrial capture threshold test and, in response to a loss of capture, for triggering the pulse generating means to deliver a backup atrial stimulation pulse concurrent with a ventricular stimulation pulse.

7. The device, as recited in claim 6, wherein:

the device further comprises timing means for controlling a plurality of intervals including a post-ventricular refractory period (PVARP); and

the control means includes means for automatically lengthening the post-ventricular refractory period (PVARP) during the capture threshold test such that the possibility of premature and retrograde P-waves being detected as true cardiac contractions is reduced.

8. The device, as recited in claim 6, wherein:

the control means includes means for automatically restoring the post ventricular refractory period (PVARP) subsequent to the capture threshold test value.